Save the Date: Wednesday, November 18th - 12:30 - 1:30pm (CST)
If anything, the pandemic has underscored just how critically valuable biotechnology innovation is to society and the economy. It will be vaccines and therapeutics that will accelerate our ability to overcome the virus and return to normal.
Looking beyond COVID-19, this industry will play an instrumental role in preparing for future pandemics and supporting the necessary economic rebuild. With this as a backdrop, the post pandemic recovery presents an important opportunity for Canada to capitalize on this reputation and expertise to take the sector to the next level globally.
To do so, we must establish the conditions that will support the creation of more companies and ultimately the establishment of anchor companies. The panel will explore through the eyes of investors the strengths and opportunities that are before Canada’s biotechnology sector as we emerge from the pandemic and look ahead to future economic and health challenges.
Register today and join the discussion virtually on November 18, 2020
BIONATION is a national dialogue platform designed to showcase the value and opportunity the biotechnology ecosystem in Canada offers. During the COVID-19 pandemic BIONATION has taken the opportunity to pivot from an in person gathering to a sustained virtual presence concentrated on showcasing Canadian companies nationwide.
The goal of BIONATION is to provide policymakers with an increased awareness of the important role Canadian biotech can play in supporting the competitiveness of key industry sectors and the Canadian economy more broadly. Key themes of talent, investment and next-gen technologies remain central to discussions.